Literature DB >> 7651003

Abnormal monitoring of inner speech: a physiological basis for auditory hallucinations.

P K McGuire1, D A Silbersweig, I Wright, R M Murray, A S David, R S Frackowiak, C D Frith.   

Abstract

Auditory verbal hallucinations ("voices") are thought to arise from a disorder of inner speech (thinking in words). We examined the neural correlates of tasks which involve inner speech in subjects with schizophrenia who hear voices (hallucinators), subjects with schizophrenia who do not (nonhallucinators), and normal controls. There were no differences between hallucinators and controls in regional cerebral blood flow during thinking in sentences. However, when imagining sentences being spoken in another person's voice--which entails both the generation and monitoring of inner speech--hallucinators had a normal left frontal response, but reduced activation in the left middle temporal gyrus and the rostral supplementary motor area, regions which were activated by both normal subjects and nonhallucinators (p < 0.001). These findings suggest that a predisposition to verbal hallucinations is associated with a failure to activate areas concerned with the monitoring of inner speech.

Entities:  

Mesh:

Year:  1995        PMID: 7651003     DOI: 10.1016/s0140-6736(95)91435-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  73 in total

Review 1.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

2.  Functional neuroimaging in mental disorders.

Authors:  Philip K McGuire; Kazunori Matsumoto
Journal:  World Psychiatry       Date:  2004-02       Impact factor: 49.548

Review 3.  [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].

Authors:  H Tost; A Meyer-Lindenberg; M Ruf; T Demirakça; O Grimm; F A Henn; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

4.  The role of self-talk in the awareness of physiological state and physical performance.

Authors:  Alan St Clair Gibson; Carl Foster
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 5.  Neurobiological Models of Self-Disorders in Early Schizophrenia.

Authors:  A Mishara; I Bonoldi; P Allen; G Rutigliano; J Perez; P Fusar-Poli; P McGuire
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

6.  Left-dominant temporal-frontal hypercoupling in schizophrenia patients with hallucinations during speech perception.

Authors:  Katie M Lavigne; Lucile A Rapin; Paul D Metzak; Jennifer C Whitman; Kwanghee Jung; Marion Dohen; Hélène Lœvenbruck; Todd S Woodward
Journal:  Schizophr Bull       Date:  2014-02-19       Impact factor: 9.306

7.  Self-face recognition in schizophrenia is related to insight.

Authors:  C Heinisch; S Wiens; M Gründl; G Juckel; M Brüne
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-14       Impact factor: 5.270

8.  Topographic analysis of individual activation patterns in medial frontal cortex in schizophrenia.

Authors:  Emily R Stern; Robert C Welsh; Kate D Fitzgerald; Stephan F Taylor
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

9.  Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study.

Authors:  Toshiaki Onitsuka; Martha E Shenton; Dean F Salisbury; Chandlee C Dickey; Kiyoto Kasai; Sarah K Toner; Melissa Frumin; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

10.  Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Authors:  Garry D Honey; Philip R Corlett; Anthony R Absalom; Michael Lee; Edith Pomarol-Clotet; Graham K Murray; Peter J McKenna; Edward T Bullmore; David K Menon; Paul C Fletcher
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.